Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice.

BACKGROUND & AIMS Early growth response-1 (Egr-1), an immediate early gene/zinc-finger transcription factor, is required for maximal stimulation of tumor necrosis factor alpha (TNF-alpha) transcription in response to lipopolysaccharide (LPS). Because chronic ethanol exposure sensitizes macrophages to LPS-stimulated TNF-alpha expression, we have investigated the role of Egr-1 in mediating increased LPS-stimulated TNF-alpha expression after chronic ethanol feeding. Furthermore, because TNF-alpha contributes to alcoholic liver injury, we tested the hypothesis that Egr-1 is required for the development of ethanol-induced fatty liver injury in wild type and egr-1 -/- mice. METHODS Wild-type and egr-1 -/- mice were fed ethanol-containing diets or pair-fed control diets for 6 weeks. RESULTS Wild-type mice fed the ethanol diet developed hepatic steatosis characterized by micro- and macrovesicular lipid accumulation. However, egr-1 -/- mice did not develop steatosis after ethanol feeding. Alanine transferase and TNF-alpha concentrations in serum were increased after ethanol feeding in wild-type but not egr-1 -/- mice. In wild-type mice, challenge with LPS increased Egr-1 messenger RNA (mRNA) and DNA binding activity in liver; this response to LPS was enhanced after chronic ethanol feeding. LPS challenge also increased hepatic TNF-alpha mRNA and serum TNF-alpha to a greater extent after ethanol feeding compared with pair-fed wild-type mice. However, chronic ethanol feeding did not enhance LPS-stimulated TNF-alpha mRNA or serum TNF-alpha in egr-1 -/- mice. CONCLUSIONS These data show that Egr-1 contributes to increased LPS-mediated TNF-alpha expression after chronic ethanol and that the absence of Egr-1 prevents chronic ethanol-induced fatty liver, as well as increased sensitivity to LPS.

[1]  J. Reimund,et al.  Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease , 1996, Journal of Clinical Immunology.

[2]  P. Hruz,et al.  Delayed Hepatocellular Mitotic Progression and Impaired Liver Regeneration in Early Growth Response-1-deficient Mice* , 2004, Journal of Biological Chemistry.

[3]  N. Kaplowitz,et al.  Role of TNF‐α in ethanol‐induced hyperhomocysteinemia and murine alcoholic liver injury , 2004 .

[4]  L. Nagy.  Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease , 2003, Experimental biology and medicine.

[5]  W. Aird,et al.  Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. , 2003, Blood.

[6]  G. Su,et al.  Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[7]  Elisabeth L. Humphris,et al.  Role of Toll-Like Receptors in Changes in Gene Expression and NF-κB Activation in Mouse Hepatocytes Stimulated with Lipopolysaccharide , 2002, Infection and Immunity.

[8]  K. Mak,et al.  Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-α generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-κB , 2002 .

[9]  Hsien-Yeh Hsu,et al.  Lipopolysaccharide-mediated Reactive Oxygen Species and Signal Transduction in the Regulation of Interleukin-1 Gene Expression* , 2002, The Journal of Biological Chemistry.

[10]  J. Hoek,et al.  Alcohol and mitochondria: a dysfunctional relationship. , 2002, Gastroenterology.

[11]  M. McMullen,et al.  Chronic Ethanol Increases Lipopolysaccharide-stimulated Egr-1 Expression in RAW 264.7 Macrophages , 2002, The Journal of Biological Chemistry.

[12]  A. Diehl,et al.  Chronic Ethanol Exposure Potentiates Lipopolysaccharide Liver Injury Despite Inhibiting Jun N-terminal Kinase and Caspase 3 Activation* , 2002, The Journal of Biological Chemistry.

[13]  G. Gores,et al.  Mechanisms of hepatotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  Jeanette R. Hill,et al.  ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[15]  M. McMullen,et al.  Stabilization of tumor necrosis factor alpha mRNA by chronic ethanol: role of A + U-rich elements and p38 mitogen-activated protein kinase signaling pathway. , 2001, The Journal of biological chemistry.

[16]  W. Aird,et al.  Epidermal growth factor induces Egr-1 promoter activity in hepatocytes in vitro and in vivo. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[17]  Joseph Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent , 2001 .

[18]  H. Tilg,et al.  Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis. , 2001 .

[19]  N. Mackman,et al.  Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. , 2001, Blood.

[20]  I. Rusyn,et al.  ICAM-1 is involved in the mechanism of alcohol-induced liver injury: studies with knockout mice. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[21]  E. Chan,et al.  Redox Paradox: Effect of N-acetylcysteine and Serum on Oxidation Reduction–sensitive Mitogen-activated Protein Kinase Signaling Pathways Materials and Methods , 2022 .

[22]  Martin Braddock,et al.  The transcription factor Egr-1: a potential drug in wound healing and tissue repair , 2001, Annals of medicine.

[23]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[24]  Nigel Mackman,et al.  Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress , 2000, Nature Medicine.

[25]  H. Tilg,et al.  Cytokines in alcoholic and nonalcoholic steatohepatitis. , 2000, The New England journal of medicine.

[26]  A. Keshavarzian,et al.  Exacerbation of alcoholic liver injury by enteral endotoxin in rats , 2000, Hepatology.

[27]  S. Targan,et al.  Tumor necrosis factor: biology and therapeutic inhibitors. , 2000, Gastroenterology.

[28]  M. Lafontan,et al.  Nitric oxide-dependent downregulation of adipocyte UCP-2 expression by tumor necrosis factor-α , 2000 .

[29]  Ian F. Dunn,et al.  A Lipopolysaccharide-Specific Enhancer Complex Involving Ets, Elk-1, Sp1, and CREB Binding Protein and p300 Is Recruited to the Tumor Necrosis Factor Alpha Promoter In Vivo , 2000, Molecular and Cellular Biology.

[30]  M. Fenton,et al.  Activation of TNF‐α transcription utilizes distinct MAP kinase pathways in different macrophage populations , 2000 .

[31]  Hiroshi Matsumoto,et al.  Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat , 1999, Hepatology.

[32]  C. McClain,et al.  Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro. , 1999, Clinical biochemistry.

[33]  K. Fitzgerald,et al.  Characterization of CD44 induction by IL-1: a critical role for Egr-1. , 1999, Journal of immunology.

[34]  K. Du,et al.  Mitogenic Up-regulation of the PRL-1 Protein-tyrosine Phosphatase Gene by Egr-1 , 1999, The Journal of Biological Chemistry.

[35]  R. Thurman,et al.  Role of endotoxin in the hypermetabolic state after acute ethanol exposure. , 1998, The American journal of physiology.

[36]  R. Thurman,et al.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. , 1998, American Journal of Physiology - Gastrointestinal and Liver Physiology.

[37]  R. Thurman.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. , 1998, American Journal of Physiology.

[38]  N. Mackman,et al.  Lipopolysaccharide Induction of the Tumor Necrosis Factor-α Promoter in Human Monocytic Cells , 1997, The Journal of Biological Chemistry.

[39]  J. Milbrandt,et al.  Luteinizing Hormone Deficiency and Female Infertility in Mice Lacking the Transcription Factor NGFI-A (Egr-1) , 1996, Science.

[40]  S. McMahon,et al.  The role of early growth response gene 1 (egr‐1) in regulation of the immune response , 1996, Journal of leukocyte biology.

[41]  J. Milbrandt,et al.  Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1) , 1996, Molecular and cellular biology.

[42]  J. Monroe,et al.  Transcriptional regulation of the Icam-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1 , 1996, The Journal of experimental medicine.

[43]  J. Stamler,et al.  Nitric oxide production in experimental alcoholic liver disease in the rat: role in protection from injury. , 1995, Gastroenterology.

[44]  B. Beutler.  TNF, immunity and inflammatory disease: lessons of the past decade. , 1995, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[45]  J. Milbrandt,et al.  Growth and Differentiation Proceeds Normally in Cells Deficient in the Immediate Early Gene NGFI-A (*) , 1995, The Journal of Biological Chemistry.

[46]  V. Sukhatme,et al.  Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. , 1995, Progress in nucleic acid research and molecular biology.

[47]  A. Nanji,et al.  Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. , 1993, The American journal of pathology.

[48]  C. McClain,et al.  Tumor necrosis factor in alcohol enhanced endotoxin liver injury. , 1992, Alcoholism, clinical and experimental research.

[49]  C. Jacob.  Tumor necrosis factor α in autoimmunity: pretty girl or old witch? , 1992 .

[50]  V. Desmet,et al.  Can hepatocytes serve as 'activated' immunomodulating cells in the immune response? , 1992, Journal of hepatology.

[51]  C. Jacob.  Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? , 1992, Immunology today.

[52]  D. Kioussis,et al.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.

[53]  A. Khoruts,et al.  Circulating tumor necrosis factor, interleukin‐1 and interleukin‐6 concentrations in chronic alcoholic patients , 1991, Hepatology.

[54]  W. Schaffner,et al.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. , 1989, Nucleic acids research.

[55]  L. Old,et al.  Tumor necrosis factor (TNF). , 1985, Science.